Innoviva

Innoviva

Pharmaceuticals
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

$1.5B

Market Cap • 1/8/2026

1996

(30 years)

Founded

2004

(22 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country